MedTrace Logo

ILIT: Follow-up of Rhinitis Quality of Life

NCT05037955 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162

Last updated 2022-03-23

No results posted yet for this study

Summary

Re-evaluation of patients treated with intralymphatic immunotherapy (ILIT) in terms of quality of life and therapeutic efficacy and comparison with subcutaneous immunotherapy (SCIT) 15 years post immunotherapy

Conditions

  • Allergic Rhinitis Due to Grass Pollen

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-07-01
Completion
2022-02-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05037955 on ClinicalTrials.gov